Photo of Kevin LaCroix

Kevin M. LaCroix is an attorney and Executive Vice President, RT ProExec, a division of RT Specialty. RT ProExec is an insurance intermediary focused exclusively on management liability issues.

A continuing debate surrounding the Sarbanes-Oxley Act has been the extent to which the Act may be discouraging foreign companies from listing their shares on U. S. securities exchanges. (Prior D & O Diary post on the topic may be found here and here.) Enforcement activity against foreign issuers undoubtedly will influence the relative

Within the last few days, we have witnessed the feuding, dysfunctional H-P Board struggling with the turmoil and adverse publicity arising from its flawed investigation of media leaks. Last week we also saw the forced ouster of Bristol Myers Squibb CEO Peter Dolan. These events follow the removal of the CEOs of some of the

On September 12, 2006, the Wall Street Journal carried an editorial entitled “The Milberg Effect,” (here, subscription required) commenting on the possible impact of the Milberg Weiss indictment on the decline in the number of securities lawsuits in 2006. (To see the Cornerstone Consulting data about the decline, refer here.) The Journal

The world of directors’ and officers’ liability often seems as if it is in a state of constant change — and it is no wonder, because so many factors affect it: legislation, litigation, volatile securities markets, and the ever-changing global economy. With so many shifting factors and varying dynamics, it can sometimes be difficult to

In recent days, there has been extensive media attention (here and here) focused on the fact that plaintiffs’ lawyers seeking to exploit the options backdating scandal are filing shareholders’ derivative suits in preference to securities fraud class action lawsuits. Indeed, The D & O Diary’s running tally of options backdating lawsuits (here